Nanalysis Scientific Corp.
NSCIF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $21,992 | $28,493 | $31,710 | $35,008 |
| - Cash | $410 | $344 | $707 | $1,376 |
| + Debt | $18,744 | $17,637 | $16,013 | $18,361 |
| Enterprise Value | $40,326 | $45,786 | $47,016 | $51,993 |
| Revenue | $9,285 | $9,576 | $10,594 | $12,289 |
| % Growth | -3% | -9.6% | -13.8% | – |
| Gross Profit | $2,029 | $2,325 | $2,716 | $4,185 |
| % Margin | 21.9% | 24.3% | 25.6% | 34.1% |
| EBITDA | -$353 | -$790 | -$3 | -$6,031 |
| % Margin | -3.8% | -8.2% | -0% | -49.1% |
| Net Income | -$1,500 | -$2,122 | -$1,307 | -$7,452 |
| % Margin | -16.2% | -22.2% | -12.3% | -60.6% |
| EPS Diluted | -0.01 | -0.02 | -0.01 | -0.066 |
| % Growth | 50% | -100% | 84.8% | – |
| Operating Cash Flow | -$309 | -$1,568 | $2,679 | $1,067 |
| Capital Expenditures | -$353 | -$437 | -$589 | -$349 |
| Free Cash Flow | -$662 | -$2,005 | $2,090 | $718 |